Comparison of the effects of vaginal estradiol and evening primrose pills in improving the visualization of the cervix during colposcopy
- Conditions
- Cesarean.Encounter for cesarean delivery without indication
- Registration Number
- IRCT20140820018866N10
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 134
Women who are candidates for colposcopy and have an unsatisfactory colposcopy
Cervical structural anomalies such as history of cervical insufficiency, Müllerian anomaly and history of conization
Having contraindications or sensitivity to evening primrose or estradiol
Cancer in the patient or a history of breast or ovarian cancer in the family
History of smoking
Active vaginal bleeding or pregnancy
Post-menopausal women with an inflammatory pap smear or persistent vaginal discharge
Taking aspirin or Flavix
History of cardiovascular diseases and thromboembolism, sexually transmitted diseases, digestive diseases and neurological diseases, hypertension and coagulopathy, liver disease
Thyroid dysfunction and thyroid medication use
Blood disorders
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Satisfactoryness of colposcopy. Timepoint: 4 weeks after the start of drug administration. Method of measurement: colposcopy.
- Secondary Outcome Measures
Name Time Method Side effects such as stomach pain, breast pain, bloating, headache, itching, nausea and vomiting, diarrhea, chest or leg pain, impaired vision or speech, skin sensitivity, abnormal vaginal bleeding, vaginal itching and irritation. Timepoint: 4 weeks after the start of drug administration. Method of measurement: Ask the patient.